TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bure Equity AB ( (SE:BURE) ) just unveiled an update.
Bure Equity AB reported a decrease in net asset value by 16.5% in the first half of 2025, with significant investment activities including acquiring a 17% stake in Silex Microsystems, a leader in MEMS foundry services. The company faced mixed performance from its portfolio companies, with notable growth in Mycronic and a significant order for Ovzon, while others like Vitrolife and Xvivo experienced challenges. The acquisition of Silex is seen as a strategic move to enhance growth opportunities amid geopolitical complexities.
More about Bure Equity AB
Bure Equity AB is an investment company focusing on long-term ownership and development of companies in various industries. It has a diversified portfolio that includes companies in technology, healthcare, and industrial sectors.
Average Trading Volume: 64,687
Technical Sentiment Signal: Sell
Current Market Cap: SEK20.88B
Learn more about BURE stock on TipRanks’ Stock Analysis page.